Henry Schein Inc. Stock
Henry Schein Inc. Stock
Henry Schein Inc. shows a slight decrease today, losing -€0.500 (-0.680%) compared to yesterday.
Our community is currently high on Henry Schein Inc. with 12 Buy predictions and 3 Sell predictions.
However, we have a potential of -8.72% for Henry Schein Inc. as the target price of 68 € is below the current price of 74.5 €.
For the coming years our community has positive and negative things to say abot the Henry Schein Inc. stock. Criterium "Company culture" gathered the most positive votes but regarding "Company culture" there were negative voices in the community.
Pros and Cons of Henry Schein Inc. in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Henry Schein Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Henry Schein Inc. | -0.680% | -1.325% | 0.676% | 25.632% | 14.721% | 3.963% | 10.403% |
| Dexcom Inc. | 11.730% | 14.921% | 22.712% | 2.289% | 26.308% | -36.099% | -33.395% |
| Baxter International | -1.250% | 15.156% | 21.576% | 19.080% | 39.209% | -44.885% | -65.225% |
| Idexx Laboratories Inc. | 0.470% | 1.232% | 5.232% | 3.524% | -17.089% | -3.868% | -15.292% |
Comments
Henry Schein (HSIC) had its price target raised by Piper Sandler from $91.00 to $95.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for HSIC provided by MarketBeat
Henry Schein (HSIC) was downgraded by Wall Street Zen from "strong-buy" to "buy".
Show more
Ratings data for HSIC provided by MarketBeat
Henry Schein (HSIC) had its "underweight" rating reaffirmed by Morgan Stanley.
Show more
Ratings data for HSIC provided by MarketBeat